FdaApplication
ANDA 207338
Identifiers
- fda_app_no: ANDA207338
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABORATORIES FL INC |
| application_type | ANDA |
| approval_date | 2017-11-17 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.8MG BASE | TABLET;SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.6MG BASE | TABLET;SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.2MG BASE | TABLET;SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.3MG BASE | TABLET;SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.1MG BASE | TABLET;SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.4MG BASE | TABLET;SUBLINGUAL |
6 products